TG3 Electronics achieves growth in first year of MedAccred program – Med-Tech Innovation
Wisconsin-based electronics company TG3 Electronics says it has raised standards and achieved significant growth following the first year of participation in the MedAccred program.
TG3 Electronics manufactures standard and custom keyboards, control panels, and custom display devices for the medical, manufacturing, government, and other markets. As a designer of custom input devices, TG3 provides the user interface that communicates to the equipment or device.
TG3 attained the MedAccred Accreditation in Printed Circuit Board Assembly, after meeting the exacting audit requirements, as set by MedAccred OEM Subscribers – Bausch Health, BD, Boston Scientific, Baxter, Edwards Lifesciences, Johnson & Johnson, Medtronic, Philips, Stryker, and Roche Diagnostics.
Tim Hansen, TG3 Electronics director of sales, said: “It’s clear that MedAccred has brought TG3 to a higher standard. We saw significant growth within the first year after our MedAccred participation and we expect more in the future.
“Much of the growth has been directly due to opportunities we have received for being a MedAccred Accredited Supplier, along with our in-house Engineering services. We continue to have a line of opportunities in our sales pipeline from multiple divisions of our sponsor company, due to our accreditation.”
TG3 Electronics has been building electronic devices for 36 years. It has been ISO 9001:2015 certified since 2005 and added ISO 13485:2016 in 2020, after deciding to pursue MedAccred Accreditation. After TG3 Electronics was awarded an initial MedAccred Accreditation for PCB Assembly in 2020, it has continued to pass subsequent audits, and the value of the rigorous MedAccred Accreditation program has proved to be significant and long-lasting.
Positive outcomes of the MedAccred process for TG3 Electronics, included:
The company says going through the process of MedAccred Accreditation has also significantly improved the quality culture at TG3 Electronics.
TG3 director of quality, Jim Rigney, explains: “MedAccred has empowered our Quality department with the leverage to make necessary changes and enforce more strict standards for the production floor. We are doing a better job of training our operators and explaining the importance of complying to MedAccred industry-managed audit criteria.
“We are changing from a reactive to preventive approach, along with catching issues at the source to fix them and reduce rework. We use tools like Process Failure Mode Effects Analysis (PFMEA), Fishbone Analysis, Design Reviews, and others to focus on preventive controls that have avoided thousands of dollars in scrap, rework, and design changes.”